ZA879472B - 3-aryloxy-3-substituted propanamines - Google Patents
3-aryloxy-3-substituted propanaminesInfo
- Publication number
- ZA879472B ZA879472B ZA879472A ZA879472A ZA879472B ZA 879472 B ZA879472 B ZA 879472B ZA 879472 A ZA879472 A ZA 879472A ZA 879472 A ZA879472 A ZA 879472A ZA 879472 B ZA879472 B ZA 879472B
- Authority
- ZA
- South Africa
- Prior art keywords
- aryloxy
- substituted propanamines
- propanamines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94512286A | 1986-12-22 | 1986-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA879472B true ZA879472B (en) | 1989-08-30 |
Family
ID=25482649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA879472A ZA879472B (en) | 1986-12-22 | 1987-12-17 | 3-aryloxy-3-substituted propanamines |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP0273658B1 (de) |
JP (1) | JP2549681B2 (de) |
KR (2) | KR880007433A (de) |
CN (1) | CN1019113B (de) |
AR (1) | AR243868A1 (de) |
AT (1) | ATE57924T1 (de) |
AU (1) | AU591007B2 (de) |
CA (1) | CA1302421C (de) |
CY (2) | CY1682A (de) |
DE (3) | DE3765919D1 (de) |
DK (1) | DK174599B1 (de) |
EG (1) | EG18230A (de) |
ES (1) | ES2019949B3 (de) |
GR (1) | GR3001207T3 (de) |
HK (1) | HK69693A (de) |
HU (1) | HU206309B (de) |
IE (1) | IE873449L (de) |
IL (1) | IL84863A (de) |
LU (1) | LU91131I2 (de) |
MX (1) | MX9845A (de) |
NL (1) | NL300171I2 (de) |
NZ (1) | NZ222980A (de) |
PH (1) | PH26556A (de) |
PT (1) | PT86389B (de) |
SG (1) | SG114992G (de) |
SU (1) | SU1598865A3 (de) |
ZA (1) | ZA879472B (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902710A (en) * | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
IL98108A0 (en) * | 1990-05-17 | 1992-06-21 | Lilly Co Eli | Chiral synthesis of 1-aryl-3-aminopropan-1-ols |
EP0571685A1 (de) * | 1992-05-27 | 1993-12-01 | Novo Nordisk A/S | Aryloxyheteroarylpropylamine, ihre Herstellung und Verwendung |
US5362886A (en) * | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
TW344661B (en) * | 1993-11-24 | 1998-11-11 | Lilly Co Eli | Pharmaceutical composition for treatment of incontinence |
GB0004152D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
GB0004153D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
GB0004151D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
GB0004149D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
SE0102640D0 (sv) | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
CA2452347A1 (en) * | 2001-07-31 | 2003-02-13 | Pharmacia & Upjohn Company | Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
AU2003217676B2 (en) | 2002-02-22 | 2009-06-11 | Takeda Pharmaceutical Company Limited | Active agent delivery systems and methods for protecting and administering active agents |
US7659409B2 (en) | 2002-03-19 | 2010-02-09 | Mitsubishi Chemical Corporation | 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same |
EP1486493A4 (de) * | 2002-03-19 | 2007-04-04 | Mitsubishi Chem Corp | 3-hydroxy-3-(2-thienyl) propionsäureamid verbindung, verfahren zu deren herstellung und verfahren zur herstellung einer 3-amino-1-(2-thienyl)-1-propanolverbindung daraus |
US20060167278A1 (en) * | 2002-05-20 | 2006-07-27 | Mitsubishi Rayon Co. Ltd. | Propanolamine derivatives, process for preparation of 3-n-methylamino-1-(2-thienyl)-1-propanols and process for preparation of propanolamine derivatives |
DE10235206A1 (de) * | 2002-08-01 | 2004-02-19 | Basf Ag | Verfahren zur Herstellung von (S)-3-Methylmino-1-(thien-2-yl)propan-1-ol |
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
GB0229583D0 (en) * | 2002-12-19 | 2003-01-22 | Cipla Ltd | A process for preparing duloxetine and intermediates for use therein |
DE10302595A1 (de) | 2003-01-22 | 2004-07-29 | Basf Ag | 3-Methylamino-1-(2-thienyl)-1-proganon, seine Herstellung und Verwendung |
DE10345772A1 (de) | 2003-10-01 | 2005-04-21 | Basf Ag | Verfahren zur Herstellung von 3-Methylamino-1-(thien-2-yl)-propan-1-ol |
DE102004004719A1 (de) | 2004-01-29 | 2005-08-18 | Basf Ag | Verfahren zur Herstellung von enantiomerenreinen Aminoalkoholen |
PL1720852T3 (pl) * | 2004-02-19 | 2012-12-31 | Lonza Ag | Sposób wytwarzania enancjomerycznie czystych 1-podstawionych-3-aminoalkoholi |
DE102004022686A1 (de) | 2004-05-05 | 2005-11-24 | Basf Ag | Verfahren zur Herstellung optisch aktiver Alkohole |
GB0410470D0 (en) * | 2004-05-11 | 2004-06-16 | Cipla Ltd | Pharmaceutical compound and polymorphs thereof |
PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
EP1784381A1 (de) | 2004-08-26 | 2007-05-16 | Neurosearch A/S | Neue substituierte aryloxyalkylamine und deren verwendung als monoamin neurotransmitter wiederaufnahmehemmer |
WO2006071868A2 (en) * | 2004-12-23 | 2006-07-06 | Teva Pharmaceutical Industries Ltd. | Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof |
MX2007011254A (es) | 2005-03-14 | 2007-10-18 | Teva Pharma | Proceso para la preparacion de (s)-(+)-n,n-dimetil-3-(1- naftaleniloxi)-3-(2-tienil)propanamina opticamente activa. |
GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
CN101495184A (zh) | 2005-07-15 | 2009-07-29 | Amr科技公司 | 芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用 |
DE102005044736A1 (de) | 2005-09-19 | 2007-03-22 | Basf Ag | Neue Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von optisch aktiven Alkanolen |
EP1838692A2 (de) * | 2005-09-22 | 2007-10-03 | Teva Pharmaceutical Industries Ltd | Dnt-maleat und herstellungsverfahren dafür |
ITMI20051970A1 (it) * | 2005-10-18 | 2007-04-19 | Solmag S P A | Processo per la preparazione di eteri misti derivanti dall'inaftolo e intermedi di forme cristalline definite di + e - duloxetina |
AU2006319233B9 (en) * | 2005-11-30 | 2011-09-29 | F. Hoffmann-La Roche Ag | 3-amino-2-arylpropyl azaindoles and uses thereof |
EP1863782A1 (de) | 2005-12-05 | 2007-12-12 | Teva Pharmaceutical Industries Ltd. | 2-(n-methyl-propanamin)-3-(2-naphthol) thiophen, eine verunreinigung von duloxetin hydrochlorid |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
DE102005062662A1 (de) | 2005-12-23 | 2007-06-28 | Basf Ag | Verfahren zur Herstellung optisch aktiver Alkohole |
DE102005062661A1 (de) | 2005-12-23 | 2007-08-16 | Basf Ag | Verfahren zur Herstellung von optisch aktivem (1S)-3-Chlor-(-thien-2-yl)-propan-1-ol |
CZ299270B6 (cs) | 2006-01-04 | 2008-06-04 | Zentiva, A. S. | Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu |
US8362279B2 (en) | 2006-01-06 | 2013-01-29 | Msn Laboratories Limited | Process for pure duloxetine hydrochloride |
ATE552250T1 (de) | 2006-12-22 | 2012-04-15 | Synthon Bv | Verfahren zur herstellung von duloxetin und verwandten verbindungen |
KR101680385B1 (ko) * | 2008-04-11 | 2016-11-28 | 넥타르 테라퓨틱스 | 올리고머-아릴옥시-치환된 프로판아민 컨쥬게이트 |
EP2133072A1 (de) | 2008-06-13 | 2009-12-16 | KRKA, D.D., Novo Mesto | Magenresistente orale pharmazeutische Zusammensetzungen mit Duloxetin oder pharmazeutisch zulässigen Derivaten |
CN101613347B (zh) * | 2008-06-23 | 2012-07-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 胺类化合物及其医药用途 |
HU230480B1 (hu) * | 2008-07-25 | 2016-07-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Eljárás N-metil-ariloxi-propánamin származékok előállítására |
WO2010025287A2 (en) | 2008-08-27 | 2010-03-04 | Codexis, Inc. | Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
US8426178B2 (en) | 2008-08-27 | 2013-04-23 | Codexis, Inc. | Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
JP5739415B2 (ja) | 2009-05-12 | 2015-06-24 | ブリストル−マイヤーズ スクウィブ カンパニー | (S)−7−([1,2,4]トリアゾロ[1,5−a]ピリジン−6−イル)−4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロイソキノリンの結晶形態およびその使用 |
DK2429296T3 (en) | 2009-05-12 | 2018-03-12 | Albany Molecular Res Inc | 7 - ([1,2,4,] TRIAZOLO [1,5, -A] PYRIDIN-6-YL) -4- (3,4-DICHLORPHENYL) -1,2,3,4- TETRAHYDROISOQUINOLINE AND USE thereof |
CZ304602B6 (cs) | 2009-09-02 | 2014-07-30 | Zentiva, K. S. | Způsob krystalizace hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (hydrochloridu duloxetinu) |
EP2377525A1 (de) | 2010-03-26 | 2011-10-19 | Laboratorios del Dr. Esteve S.A. | Enterische Duloxetin-Tabletten |
EP2558455B1 (de) | 2010-04-13 | 2017-08-09 | KRKA, D.D., Novo Mesto | Synthese von duloxetin- und/oder pharmazeutisch akzeptablen salzen daraus |
US9045468B2 (en) | 2010-08-17 | 2015-06-02 | Albany Molecular Research, Inc. | 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
EP2508519A1 (de) * | 2011-04-07 | 2012-10-10 | Bioindustria Laboratorio Italiano Medicinali S.p.A In forma abbreviata Bioindustria L.I.M. S.p.A. | Verfahren zur Herstellung von Duloxetin und seinem Hydrochloridsalz |
GR1007725B (el) | 2011-10-17 | 2012-10-18 | Φαρματεν Αβεε, | Μεθοδος δια την παρασκευη υδροχλωρικης ντουλοξετινης υψηλης καθαροτητας |
PL224543B1 (pl) | 2013-08-21 | 2017-01-31 | Pabianickie Zakłady Farm Polfa Spółka Akcyjna | Dojelitowa tabletka duloksetyny |
US9668975B2 (en) | 2014-10-14 | 2017-06-06 | PharmaDax Inc. | Method of preparing drug agglomerate |
CN105777706B (zh) | 2014-12-25 | 2019-08-23 | 江苏恩华药业股份有限公司 | 一种3-[(苯并[d][1, 3]二氧戊环-4-基)-氧基]-3-芳基丙胺类化合物及其应用 |
JP2016222628A (ja) * | 2015-06-03 | 2016-12-28 | 株式会社トクヤマ | デュロキセチン塩酸塩の製造方法 |
JP6182183B2 (ja) * | 2015-07-07 | 2017-08-16 | 東和薬品株式会社 | デュロキセチン塩基及びデュロキセチン塩酸塩の製造方法 |
CN106349211B (zh) * | 2016-08-26 | 2020-10-16 | 江苏恩华药业股份有限公司 | 2-甲基-3-芳氧基-3-杂芳基丙胺类化合物及应用 |
EP3339304A1 (de) | 2016-12-20 | 2018-06-27 | Laboratorios del Dr. Esteve, S.A. | Neue chinolin- und isochinolinderivate zur behandlung von schmerzen und schmerzbedingten leiden |
US20220213075A1 (en) * | 2019-05-16 | 2022-07-07 | Shanghai Leado Pharmatech Co. Ltd. | 3-aryloxy-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2842555A (en) * | 1954-07-27 | 1958-07-08 | Burroughs Wellcome Co | Method of preparing quaternary salts of amino carbinols |
AT255400B (de) * | 1965-03-22 | 1967-07-10 | Chemie Linz Ag | Verfahren zur Herstellung von neuen basischen Äthern |
US3423510A (en) * | 1966-08-31 | 1969-01-21 | Geigy Chem Corp | 3-(p-halophenyl) - 3 - (2'-pyridyl-n-methylpropylamine for the treatment of depression |
US4018895A (en) * | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
FR2482956A1 (fr) * | 1980-05-22 | 1981-11-27 | Synthelabo | Cyclohexylalkylamines, leurs procedes de preparation et leur application en therapeutique |
-
1986
- 1986-12-18 KR KR860014449A patent/KR880007433A/ko unknown
-
1987
- 1987-12-17 AU AU82660/87A patent/AU591007B2/en not_active Expired
- 1987-12-17 IL IL84863A patent/IL84863A/xx not_active IP Right Cessation
- 1987-12-17 PT PT86389A patent/PT86389B/pt unknown
- 1987-12-17 ZA ZA879472A patent/ZA879472B/xx unknown
- 1987-12-17 SU SU874203804A patent/SU1598865A3/ru active
- 1987-12-17 DK DK198706648A patent/DK174599B1/da not_active IP Right Cessation
- 1987-12-17 CA CA000554601A patent/CA1302421C/en not_active Expired - Lifetime
- 1987-12-17 EG EG731/87A patent/EG18230A/xx active
- 1987-12-18 HU HU875863A patent/HU206309B/hu unknown
- 1987-12-18 EP EP87311181A patent/EP0273658B1/de not_active Expired - Lifetime
- 1987-12-18 JP JP62322617A patent/JP2549681B2/ja not_active Expired - Lifetime
- 1987-12-18 IE IE873449A patent/IE873449L/xx not_active IP Right Cessation
- 1987-12-18 ES ES87311181T patent/ES2019949B3/es not_active Expired - Lifetime
- 1987-12-18 DE DE8787311181T patent/DE3765919D1/de not_active Expired - Lifetime
- 1987-12-18 PH PH36267A patent/PH26556A/en unknown
- 1987-12-18 DE DE200512000002 patent/DE122005000002I1/de active Pending
- 1987-12-18 NZ NZ222980A patent/NZ222980A/xx unknown
- 1987-12-18 DE DE19873765919 patent/DE122005000002I2/de active Active
- 1987-12-18 MX MX984587A patent/MX9845A/es unknown
- 1987-12-18 AR AR87309638A patent/AR243868A1/es active
- 1987-12-18 AT AT87311181T patent/ATE57924T1/de active
- 1987-12-18 KR KR1019870014449A patent/KR960003808B1/ko not_active IP Right Cessation
- 1987-12-18 CN CN87108175A patent/CN1019113B/zh not_active Expired
-
1990
- 1990-12-18 GR GR90401079T patent/GR3001207T3/el unknown
-
1992
- 1992-11-04 SG SG1149/92A patent/SG114992G/en unknown
-
1993
- 1993-07-22 HK HK696/93A patent/HK69693A/xx not_active IP Right Cessation
- 1993-10-10 CY CY1682A patent/CY1682A/xx unknown
-
2005
- 2005-01-26 LU LU91131C patent/LU91131I2/fr unknown
- 2005-01-27 CY CY200500001C patent/CY2005001I1/el unknown
- 2005-01-31 NL NL300171C patent/NL300171I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR243868A1 (es) | Procedimiento para obtener 3-fenoxi o 3-naftiloxi propanaminas-3-sustituidas y sus sales | |
AU99209S (en) | Whirlpool-spa | |
AU98619S (en) | Gamesboard | |
CS1003586A1 (en) | Zpusob tepelneho zpracovani povrchu tenkostennych tvarovanych trubkovitych strojnich nebo konstrukcnich soucasti | |
CA57624S (en) | Chemisier | |
CA55743S (en) | Boardgame | |
CA57575S (en) | Vitrine | |
CA57574S (en) | Vitrine | |
CA57727S (en) | Loudspeaker-cabinet | |
CA57366S (en) | Loudspeaker-cabinet | |
CA56534S (en) | Boardgame | |
CA57305S (en) | Dictating-machine | |
CA56175S (en) | Presse-ail | |
AU97591S (en) | Brick-tie | |
AU100631S (en) | Wax-applicator | |
AU96953S (en) | Shinguard | |
AU96582S (en) | Brick-tie | |
AU97254S (en) | Sun-shield | |
AU97908S (en) | Gamesboard | |
AU96230S (en) | Sweat-shirt | |
AU96115S (en) | Teatowel | |
AU95447S (en) | Tinsnips | |
AU95106S (en) | Tea-towel | |
AU95105S (en) | Tea-towel | |
BG42967A1 (en) | Hemiluminometer |